<html lang="en">
<head>
<meta charset="utf-8"/>
<title offset="709">Dimethylargininase</title>
<script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_SVG.js" type="text/javascript">
</script>
</head>
<body>
<h1>Dimethylargininase</h1>
<hr/>

<p>In the field of <a class="uri" href="enzymology" title="wikilink">enzymology</a>, a <strong>dimethylargininase</strong>, also known as a <strong>dimethylarginine dimethylaminohydrolase</strong> (<strong>DDAH</strong>), is an <a class="uri" href="enzyme" title="wikilink">enzyme</a> that <a href="catalysis" title="wikilink">catalyzes</a> the <a href="chemical_reaction" title="wikilink">chemical reaction</a>:</p>
<dl>
<dd>N-omega,N-omega'-methyl-L-arginine + H<sub>2</sub>O 

<math display="inline" id="Dimethylargininase:0">
 <semantics>
  <mo>⇌</mo>
  <annotation-xml encoding="MathML-Content">
   <ci>normal-⇌</ci>
  </annotation-xml>
  <annotation encoding="application/x-tex">
   \rightleftharpoons
  </annotation>
 </semantics>
</math>

 dimethylamine + L-citrulline
</dd>
</dl>

<p>Thus, the two <a href="substrate_(biochemistry)" title="wikilink">substrates</a> of this enzyme are <a href="asymmetric_dimethylarginine" title="wikilink">N-omega,N-omega'-methyl-L-arginine</a> and <a href="water" title="wikilink">H<sub>2</sub>O</a>, whereas its two <a href="product_(chemistry)" title="wikilink">products</a> are <a class="uri" href="dimethylamine" title="wikilink">dimethylamine</a> and <a class="uri" href="L-citrulline" title="wikilink">L-citrulline</a>.</p>
<h2 id="isozymes">Isozymes</h2>

<p>Dimethylarginine dimethylaminohydrolase is an enzyme found in all <a href="mammal" title="wikilink">mammalian</a> <a href="Cell_(biology)" title="wikilink">cells</a>. Two isoforms exist, DDAH I and DDAH II, with some differences in tissue distribution of the two isoforms<a class="footnoteRef" href="#fn1" id="fnref1"><sup>1</sup></a>). The enzyme degrades <a href="methylarginine" title="wikilink">methylarginines</a>, specifically <a href="asymmetric_dimethylarginine" title="wikilink">asymmetric dimethylarginine</a> (ADMA) and <a class="uri" href="NG-monomethyl-L-arginine" title="wikilink">NG-monomethyl-L-arginine</a> (MMA).</p>
<table>
<tbody>
<tr class="odd">
<td style="text-align: left;">
<p>{{protein</p></td>
<td style="text-align: left;">
<p>Name=dimethylarginine dimethylaminohydrolase 1</p></td>
<td style="text-align: left;">
<p>caption=</p></td>
<td style="text-align: left;">
<p>image=</p></td>
<td style="text-align: left;">
<p>width=</p></td>
<td style="text-align: left;">
<p>HGNCid=2715</p></td>
<td style="text-align: left;">
<p>Symbol=DDAH1</p></td>
<td style="text-align: left;">
<p>AltSymbols=</p></td>
<td style="text-align: left;">
<p>EntrezGene=23576</p></td>
<td style="text-align: left;">
<p>OMIM=604743</p></td>
<td style="text-align: left;">
<p>RefSeq=NM_012137</p></td>
<td style="text-align: left;">
<p>UniProt=O94760</p></td>
<td style="text-align: left;">
<p>PDB=</p></td>
<td style="text-align: left;">
<p>ECnumber=3.5.3.18</p></td>
<td style="text-align: left;">
<p>Chromosome=1</p></td>
<td style="text-align: left;">
<p>Arm=p</p></td>
<td style="text-align: left;">
<p>Band=22</p></td>
<td style="text-align: left;">
<p>LocusSupplementaryData= }}</p></td>
<td style="text-align: left;">
<p>{{protein</p></td>
<td style="text-align: left;">
<p>Name=dimethylarginine dimethylaminohydrolase 2</p></td>
<td style="text-align: left;">
<p>caption=</p></td>
<td style="text-align: left;">
<p>image=</p></td>
<td style="text-align: left;">
<p>width=</p></td>
<td style="text-align: left;">
<p>HGNCid=2716</p></td>
<td style="text-align: left;">
<p>Symbol=DDAH2</p></td>
<td style="text-align: left;">
<p>AltSymbols=</p></td>
<td style="text-align: left;">
<p>EntrezGene=23564</p></td>
<td style="text-align: left;">
<p>OMIM=604744</p></td>
<td style="text-align: left;">
<p>RefSeq=NM_013974</p></td>
<td style="text-align: left;">
<p>UniProt=O95865</p></td>
<td style="text-align: left;">
<p>PDB=</p></td>
<td style="text-align: left;">
<p>ECnumber=3.5.3.18</p></td>
<td style="text-align: left;">
<p>Chromosome=6</p></td>
<td style="text-align: left;">
<p>Arm=p</p></td>
<td style="text-align: left;">
<p>Band=21</p></td>
<td style="text-align: left;">
<p>LocusSupplementaryData= }}</p></td>
</tr>
</tbody>
</table>
<h2 id="function">Function</h2>

<p>The methylarginines ADMA and MMA inhibit the production of <a href="nitric_oxide_synthase" title="wikilink">nitric oxide synthase</a>.<a class="footnoteRef" href="#fn2" id="fnref2"><sup>2</sup></a> As such, DDAH is important in removing methylarginines, generated by protein degradation, from accumulating and inhibiting the generation of nitric oxide.</p>
<h2 id="clinical-significance">Clinical significance</h2>

<p><a href="Enzyme_inhibition" title="wikilink">Inhibition</a> of DDAH activity causes methylarginines to accumulate, blocking <a href="nitric_oxide" title="wikilink">nitric oxide</a>(NO) synthesis and causing <a class="uri" href="vasoconstriction" title="wikilink">vasoconstriction</a>.<a class="footnoteRef" href="#fn3" id="fnref3"><sup>3</sup></a> An impairment of DDAH activity appears to be involved in the elevation of plasma ADMA, and impairment of vascular relaxation observed in humans with <a href="cardiovascular_disease" title="wikilink">cardiovascular disease</a> or risk factors (such as <a class="uri" href="hypercholesterolemia" title="wikilink">hypercholesterolemia</a>, <a href="diabetes_mellitus" title="wikilink">diabetes mellitus</a>, and <a href="insulin_resistance" title="wikilink">insulin resistance</a>). The activity of DDAH is impaired by <a href="oxidative_stress" title="wikilink">oxidative stress</a>, permitting ADMA to accumulate. A wide range of pathologic stimuli induce endothelial oxidative stress such as oxidized <a class="uri" href="LDL-cholesterol" title="wikilink">LDL-cholesterol</a>, <a href="inflammation" title="wikilink">inflammatory</a> <a class="uri" href="cytokines" title="wikilink">cytokines</a>, <a class="uri" href="hyperhomocysteinemia" title="wikilink">hyperhomocysteinemia</a>, <a class="uri" href="hyperglycemia" title="wikilink">hyperglycemia</a> and <a href="infectious_agents" title="wikilink">infectious agents</a>. Each of these insults attenuates DDAH activity <em>in vitro</em> and <em>in vivo</em>.<a class="footnoteRef" href="#fn4" id="fnref4"><sup>4</sup></a><a class="footnoteRef" href="#fn5" id="fnref5"><sup>5</sup></a><a class="footnoteRef" href="#fn6" id="fnref6"><sup>6</sup></a><a class="footnoteRef" href="#fn7" id="fnref7"><sup>7</sup></a> The attenuation of DDAH allows ADMA to accumulate, and to block NO synthesis. The adverse effect of these stimuli can be reversed in vitro by <a class="uri" href="antioxidants" title="wikilink">antioxidants</a>, which preserve the activity of DDAH.</p>

<p>The sensitivity of DDAH to oxidative stress is conferred by a critical <a class="uri" href="sulfhydryl" title="wikilink">sulfhydryl</a> in the <a href="active_site" title="wikilink">active site</a> of the enzyme that is required for the <a class="uri" href="metabolism" title="wikilink">metabolism</a> of ADMA. This sulfhydryl can also be reversibly inhibited by NO in an elegant form of <a href="negative_feedback" title="wikilink">negative feedback</a>.<a class="footnoteRef" href="#fn8" id="fnref8"><sup>8</sup></a> <a class="uri" href="Homocysteine" title="wikilink">Homocysteine</a> (a putative cardiovascular risk factor) mounts an oxidative attack on DDAH to form a mixed <a class="uri" href="disulfide" title="wikilink">disulfide</a>, inactivating the enzyme.<a class="footnoteRef" href="#fn9" id="fnref9"><sup>9</sup></a> By <a href="oxidation" title="wikilink">oxidizing</a> a sulfhydryl <a href="functional_group" title="wikilink">moiety</a> critical for DDAH activity, homocysteine and other risk factors cause ADMA to accumulate and to suppress <a href="nitric_oxide_synthase" title="wikilink">nitric oxide synthase</a> (NOS) activity.</p>

<p>The critical role of DDAH activity in regulating NO synthesis <em>in vivo</em> was demonstrated using a <a class="uri" href="transgenic" title="wikilink">transgenic</a> DDAH <a class="uri" href="mouse" title="wikilink">mouse</a>.<a class="footnoteRef" href="#fn10" id="fnref10"><sup>10</sup></a> In this animal, the activity of DDAH is increased, and <a href="Blood_plasma" title="wikilink">plasma</a> ADMA levels are reduced by 50%. The reduction in plasma ADMA is associated with a significant increase in NOS activity, as plasma and <a href="urine" title="wikilink">urinary</a> <a class="uri" href="nitrate" title="wikilink">nitrate</a> levels are doubled. The increase in NOS activity translates into a 15mmHg reduction in <a href="Systole_(medicine)" title="wikilink">systolic</a> <a href="blood_pressure" title="wikilink">blood pressure</a> in the transgenic mouse. This study provides evidence for the importance of DDAH activity and plasma ADMA levels in the regulation of NO synthesis. Subsequent studies have shown that DDAH transgenic animals also manifest improvements in <a class="uri" href="endothelial" title="wikilink">endothelial</a> <a href="Regeneration_(biology)" title="wikilink">regeneration</a> and <a class="uri" href="angiogenesis" title="wikilink">angiogenesis</a>, and reduced vascular obstructive disease, in association with the reduced plasma levels of ADMA.<a class="footnoteRef" href="#fn11" id="fnref11"><sup>11</sup></a><a class="footnoteRef" href="#fn12" id="fnref12"><sup>12</sup></a> These findings are consistent with evidence from a number of groups that nitric oxide plays a critical role in vascular regeneration. By contrast, elevations in ADMA impair angiogenesis. These insights into the role of DDAH in degrading endogenous inhibitors of NOS, and thereby maintaining vascular NO production, may have important implications in vascular health and therapy for cardiovascular disease.</p>
<h2 id="references">References</h2>
<h2 id="see-also">See also</h2>
<ul>
<li><a href="Protein_detoxification" title="wikilink">Protein detoxification</a></li>
</ul>
<h2 id="further-reading">Further reading</h2>
<ul>
<li></li>
</ul>
<h2 id="external-links">External links</h2>
<ul>
<li></li>
</ul>

<p>"</p>

<p><a href="Category:EC_3.5.3" title="wikilink">Category:EC 3.5.3</a> <a href="Category:Enzymes_of_known_structure" title="wikilink">Category:Enzymes of known structure</a></p>
<section class="footnotes">
<hr/>
<ol>
<li id="fn1">Leiper JM, Santa Maria J, Chubb A et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J. 1999; 343: 209-214.<a href="#fnref1">↩</a></li>
<li id="fn2"><a href="#fnref2">↩</a></li>
<li id="fn3"><a href="#fnref3">↩</a></li>
<li id="fn4"><a href="#fnref4">↩</a></li>
<li id="fn5"><a href="#fnref5">↩</a></li>
<li id="fn6"><a href="#fnref6">↩</a></li>
<li id="fn7"><a href="#fnref7">↩</a></li>
<li id="fn8"><a href="#fnref8">↩</a></li>
<li id="fn9"></li>
<li id="fn10"><a href="#fnref10">↩</a></li>
<li id="fn11"><a href="#fnref11">↩</a></li>
<li id="fn12"><a href="#fnref12">↩</a></li>
</ol>
</section>
</body>
</html>
